Clinical Trials List
Protocol NumberCKJX839C12001B
Active
2023-07-27 - 2027-07-31
Phase III
Terminated1
ICD-10E78.0
Pure hypercholesterolemia
ICD-9272.0
Pure hypercholesterolemia
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 陳隆景 無
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
1 participants
-
Global
154 participants
